Innospec (IOSP) Stock: Buy, Sell, or Hold?

IOSP - Innospec Inc.

CHEMICALS & ALLIED PRODUCTS
$99.89
-1.52 (-1.50%) ▼
5d: +1.27%
30d: +4.96%
90d: +16.86%
WAIT
LOW Confidence
Analysis Updated: Oct 30, 2026 12:00 AM ET
Earnings: Nov 03, 2026 2d

Get Alerted When IOSP Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 MIXED SIGNALS: IOSP shows conflicting indicators. Wait for confirmation before entering.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$165.72
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$102.90
2.9% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.8x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: IOSP is currently trading at $99.89, which is considered extended relative to its 30-day fair value range of $95.82 to $99.45. From a valuation perspective, the stock is trading at a premium (Forward PE: 16.2) compared to its historical average (13.8). At these levels, the market is pricing in 5.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, IOSP is in a strong uptrend. The price is approaching resistance at $102.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: IOSP scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $95.82 - $99.45
Company Quality Score 52/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 22.9%

All Signals

  • BEARISH: Price extended above range
  • BEARISH: Weak technical setup (32/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($101.00)
  • NEUTRAL: Trading at premium valuation - market expects 5.4% growth which is achievable
  • WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $95.82 - $99.45
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $96.32
Resistance Level $102.00
Current Trend Strong Uptrend
Technical data as of Oct 30, 2026

Fundamental Context

Forward P/E (Next Year Est.) 16.20
Wall Street Target $101.00 (+1.1%)
Revenue Growth (YoY) 11.8%
Earnings Growth (YoY) 33.0%
Profit Margin 6.6%
Valuation Premium vs History +5.4% premium
PE vs Historical 16.2 vs 13.8 STRETCHED
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +5.4% (market-implied from PE analysis)
1-Year Target $105.28 (+5%)
2-Year Target $110.97 (+11%)
3-Year Target $116.96 (+17%)
3-Yr Target (if PE normalizes) (PE: 16→14) PE COMPRESSION $99.64 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 19.9, Growth: 25.3%) $241.15 (+141%)
Base: (SPY PE: 16.2, Growth: 25.3%) $196.69 (+97%)
Bear: (PE: 13.8, Growth: 25.3%) $167.19 (+67%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 20.70 | Current EPS (TTM): $4.90
Bull Case $140.39 (+41%)
Analyst growth 25.9%, PE expands to 22.8
Base Case $127.63 (+28%)
Market implied 25.9%, PE stable at 20.7
Bear Case $68.96 (-31%)
Severe decline -20.0%, PE contracts to 17.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 30, 2026 8:08 PM ET
Data refreshes hourly during market hours. Next update: 9:08 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for IOSP.

Create Free Account

Already have an account? Log In

Top Rated Specialty Chemicals Stocks

Top-rated stocks in Specialty Chemicals by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
LIN
Linde plc Ordinary Shares
STRONG BUY
29 analysts
$545 48 HOLD
ECL
Ecolab Inc
STRONG BUY
24 analysts
$325 55 HOLD
SHW
Sherwin-Williams Co
BUY
29 analysts
$383 60 HOLD
ALB
Albemarle Corp
BUY
23 analysts
$156 65 BUY
APD
Air Products and Chemica…
BUY
23 analysts
$343 44 HOLD

More Analysis for IOSP

IOSP Technical Chart IOSP Price Prediction IOSP Earnings Date IOSP Investment Advisor IOSP Fair Price Analyzer IOSP Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals